Fulton Breakefield Broenniman LLC Amgen Inc Transaction History

Fulton Breakefield Broenniman LLC

$1.28 Billion
Q1 2024

A detailed history of Fulton Breakefield Broenniman LLC transactions in Amgen Inc stock. As of the latest transaction made, Fulton Breakefield Broenniman LLC holds 6,403 shares of AMGN stock, worth $1.99 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

6,403

Previous 7,313 12.44%

Holding current value

$1.99 Million

Previous $2.11 Million 13.58%

% of portfolio

0.14%

Previous 0.17%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $244,671 - $295,349	-910 Reduced 12.44%	6,403 $1.82 Million
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $209,929 - $236,825	-821 Reduced 10.09%	7,313 $2.11 Million
Q3 2023 Oct 20, 2023	SELL	$218.65 - $271.46 $31,266 - $38,818	-143 Reduced 1.73%	8,134 $2.19 Million
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $6,322 - $7,705	-28 Reduced 0.34%	8,277 $2 Million
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $265,674 - $337,571	1,160 Added 16.24%	8,305 $2.18 Million

Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $40,627 - $45,820	-181 Reduced 2.47%	7,145 $1.61 Million
Q2 2022 Jul 28, 2022	BUY	$230.71 - $256.74 $1.69 Million - $1.88 Million	7,326 New	7,326 $1.78 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $1.83 Million - $2.03 Million	-8,353 Closed	0 $0
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $368,922 - $422,198	1,855 Added 28.55%	8,353 $1.88 Million
Q3 2021 Oct 25, 2021	SELL	$212.27 - $248.7 $59,011 - $69,138	-278 Reduced 4.1%	6,498 $1.38 Million
Q2 2021 Jul 27, 2021	BUY	$233.58 - $259.14 $11,912 - $13,216	51 Added 0.76%	6,776 $1.65 Million
Q1 2021 Apr 09, 2021	BUY	$221.91 - $258.6 $158,443 - $184,640	714 Added 11.88%	6,725 $1.67 Million
Q4 2020 Jan 14, 2021	SELL	$216.38 - $257.67 $184,355 - $219,534	-852 Reduced 12.41%	6,011 $1.38 Million
Q3 2020 Oct 20, 2020	SELL	$234.65 - $260.95 $36,370 - $40,447	-155 Reduced 2.21%	6,863 $1.74 Million
Q1 2020 Apr 10, 2020	SELL	$182.24 - $241.7 $86,928 - $115,290	-477 Reduced 6.36%	7,018 $1.42 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $28,759 - $36,966	-152 Reduced 1.99%	7,495 $1.81 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $1.33 Million - $1.6 Million	7,647 New	7,647 $1.48 Million
Q1 2019 Apr 17, 2019	SELL	$180.87 - $203.88 $2.61 Million - $2.94 Million	-14,415 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$178.4 - $208.25 $209,976 - $245,110	-1,177 Reduced 7.55%	14,415 $2.81 Million
Q3 2018 Oct 24, 2018	SELL	$185.29 - $208.89 $148,232 - $167,112	-800 Reduced 4.88%	15,592 $3.23 Million
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $3.97 Million - $4.46 Million	-23,912 Reduced 59.33%	16,392 $3.03 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $3,049 - $3,564	-18 Reduced 0.04%	40,304 $6.87 Million
Q4 2017 Jan 30, 2018	BUY	$168.79 - $188.59 $22,617 - $25,271	134 Added 0.33%	40,322 $7.01 Million
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $6.72 Million - $7.68 Million	40,188	40,188 $7.49 Million

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Breakefield Broenniman LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fulton Breakefield Broenniman LLC with notifications on news.

Account

Fulton Breakefield Broenniman LLC Amgen Inc Transaction History